CA1045296A - Method for producing new biologically tolerated polymers - Google Patents

Method for producing new biologically tolerated polymers

Info

Publication number
CA1045296A
CA1045296A CA174,171A CA174171A CA1045296A CA 1045296 A CA1045296 A CA 1045296A CA 174171 A CA174171 A CA 174171A CA 1045296 A CA1045296 A CA 1045296A
Authority
CA
Canada
Prior art keywords
polymerization
carried out
dienols
group
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA174,171A
Other languages
French (fr)
Other versions
CA174171S (en
Inventor
Jiri Vacik
Karel Ulbrich
Jindrich Kopecek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Czech Academy of Sciences CAS
Original Assignee
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Czech Academy of Sciences CAS filed Critical Czech Academy of Sciences CAS
Application granted granted Critical
Publication of CA1045296A publication Critical patent/CA1045296A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F36/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds
    • C08F36/02Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds the radical having only two carbon-to-carbon double bonds
    • C08F36/04Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds the radical having only two carbon-to-carbon double bonds conjugated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Eyeglasses (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

ABSTRACT OF THE DISCLOSURE

The invention is concerned with a method for producing polymers which are biologically acceptable, because of their elastic properties due to a system of conjugated double bonds in their molecule, and their hydrophilic properties due to the presence of -OH groups in their molecule. This method comprises polymerizing monomers containing at least 60 mole % of dienols having 5 - 10 carbon atoms and at least one -OH group, preferably in the presence of a solvent, according to a radical mechanism or an ionic coordination mechanism, by using an azo initiator, or in the presence of a catalyst consisting of a mixture of an polyalkyl aluminium with Rh acetylacetonate, Co acetylacetonate or TiCl3, respectively, with the proviso that when the polymeri-zation is carried out according to an ionic coordination mecha-nism, the -OH groups of the dienols are previously blocked in a reversible manner by reaction with Cl-Si(CH3)3. Soluble polymers can be prepared by polymerization to a low conversion degree or by polymerization at high dilution, or in the presence of chain transfer agents such as CBr4, mercaptans, etc... Three-dimensional, cross linked polymers can be prepared by polymerization in the presence of a cross linking agen or by cross linking of the soluble polymers, especially if the polymer contains both -OH
groups and double bonds.

Description

lO~S296 The invention relates to a method for producingbiologically acceptable polymers.
Methods are known for preparing various hydrophilic polymers from hydrophilic esters of methacrylic or acrylic acid or hydrophic esters of acrylamide, methacrylamide or their N-substituted derivatives, and also copolymers thereof with various other comonomers. The so prepared hydrophilic polymers cannot be used for many applications, in particular bio medical application, essentially because of their mechanical properties. Up to now, attemps to prepare hydrophilic elastomers meeting the bio medical requirements have been unsuccessful.

-The subject invention proposes a method for producing ; polymers which are biologically acceptable, elastic due to a ~ system of conjugated double bonds in their molecules, and .~, hydrophilic because they contain one or two -OH groups in their molecule.
; -.~: :
The method for producing such polymers according to the present invention comprises the step of polymerizing monomers : containing at least 60 mole % of dienols having 5 - 10 carbon .. . ..
atoms in a straight chain and at least one -OH group prefera~ly in the presence of a solvent such as for example, alcohols having 1 to 5 carbon atoms, dimethylformamide, dimethylsulfoxide, glycol monoethylether, pyridine, benzene, and the like. The polymeriza-tion is carried out according to a radical mechanism or an ionic coordination mechanism, by using an azo initiator or in the presence of a catalyst consisting of a mixture of a polyalkyl aluminium with Rh acetylacetonate, Co acetylacetonate or TiC13, respectively, with the proviso that when the polymerization is carried out according to an ionic coordination mechanism, the --OH groups of the dienols are previously blocked in a reversible manny by reaction with Cl-Si(CH3)3 and subsequently released by hydrolisis.

C ' ~

:.

,., - ;
,,".,,~,;, , . ' ' .

5;~6 ; In accordance wlth the present invention, the polymerization can be carried out without solvent.
Soluble polymers can be prepared by polymerization to a low conversion degree or by polymerization at high dilution, or in the presence of chain transfer agents such as CBr4, mer-captans, etc...
Three-dimensional, cross-linked polymers can be prepared by polymerization in the presence of a cross-linking agent, such as glycol dimethacrylate, 1,6-heptadiene-4-ol, divinyl carbinol, methylene bis-acrylamide, l,l,l-trimethyl-propane triacrylate, bis phenol A dimethacrylate, 1,5-hexadiene-~:.:
l-ol, etc., in the amount of 0.1 - 30% by weight. Three-dimensional polymers can be also prepared by cross-linking the soluble polymers, especially if the polymer contains both -OH groups and double bonds. Thls cross-linking can be carried out by means of diisocynates, ammonium bichromate, dialdehydes, dicarboxylic acids and other bifunctional compounds capable of reacting with the -OH groups or the -C~C- bonds which are present in the polymer.
In accordance with the present invention, polymerization or copolymerization of the monomers can be carried out according to radical mechanism by using an azo initiator. If the free -OH
group in the dienols are blocked by reaction with Cl-Si(CH3)3, the polymerization or copolymerization can be carried out according to an ionic coordination mechanism in the presenceof a catalyst such as diethylaluminium chloride ~Rh acetylacetonate, diethyla-luminium chloride ~Co acetylacetonate, triisobutylaluminium tTiC13 and the like. The so formed polymer is hydrolyzed after the polymerization has been completed, to release the -OH groups and thus to obtain the stereoregular hydrophilic elastomer.
The biological compatibility of the polymer was esta-blished by proceeding to a subcutaneous implantationof the polymer to 50 rats and 5 pigs. Samples were examined at the end ~J .

, ~

: 1~45;~96 of 1st, 2nd, 3rd, and 4th weeks, and 2nd, 3rd, 4th, 5th, 6th and 12th months from the implantation. The polymers are healed by encapsulation with a capsule formed by positively stained colla-gen fibers and few fibrocytes, which were located in the ` fundamental substance; they were positively stained by Alciane blue and gave a positive reaction on glycoproteins. The collagen fibers are oriented parallel with the implant surface. Giant multinucle cells were not found in the surrounding of the implant.
The aforesaid tests have therefore positively established that the polymer according to the invention is biologically compatible.
- In accordance with the present invention, the dienols can be copolymerized with numerous monomers, such as glycol methacrylates, either alone or even in admixtures (glycol is meant to include not only simple ethylene glycol, but also -dimethylene glycol, triethylene glycol and other homolegous ", polyglycols, i.e. all hydrophilic diols of this type), N-substituted amides of methacrylic and acrylic acid, methacryloni-trile, acrylonitrile, monomers containing ionogenic groups, e.g.
methacrylic and acrylic acids, ~-vinyl-acrylic acid, vinyl pyridine, diethylaminoethyl methacrylate, and a number of other compounds which contain a polymerizable double bond.
The polymers according to the invention are especially ` suitable for the preparation of bio medical materials, such as tubular implants, heart valves, contact lenses, cosmetic implants, membranes haemodialysis and reverse osmosis. Because of the ~; excellent elastic properties of the film formed, the soluble -polymer can be used for the formation of elastic coats. These coats may be used in a non-cross linked form or they can also be cross-linked. They find various applications, form coats for ~ catheters or foods, to protection of roads and building materials.
The invention will be understood with reference to the following non-restricting examples.

. . . . . : . .

lV45;~96 A mixture, consisting of 98 parts of 2,4-pentadiene-l-ol, 1,9 parts of ethylene dimethacrylate and 0.1 part of azobisisobutyronitrile, was charged into a Teflon (trademark~
mold, through which nitrogen which was bubbed and was polymerized in an inert atmosphere for 20 hours at 70C. The obtained polymer has the shape of the old and, after swelling in a physiological saline solution and sterilization (eAg. 30 minutes in an autocla-ve at 120C or by irradiation), may be used as an artificial heart valve.

A mixture, consisting of 85 parts of 1,3-decadiene-8, 9-diol, 10 parts of ~-vinylacrylic acid, 10 parts of diethylamino-ethyl methacrylate, 10 parts of triethylene glycol dimethacrylate and 5 parts of azobisisobutyronitrile, is polymerized for 10 hours at 80 C in an inert atmosphere in a glass mold. The polymer can be used for implants after equilibrium swelling in a physiological saline solution and sterilization.
2,4-pentadiene-1-oxytrimethylsilane (10 parts), prepa-red by reaction of 2,4-pentadiene-1-ol with chlorotrimethylsilane in a benzene solution, is mixed with 90 parts of benzene in a glass ampoule sealed with a rubber closure. Into the mixture, 5xlO 3 mol/l of diethylaluminium chloride is added. Traces of oxygen are removed in vacuo and, in an inert atmosphere, 10 mol/l rhodium acetylacetonate is added. The polymerization is ~ -carried out and for 10 hours at 20 C. The polymer formed is precipitated into ether, dissolved in ethanol and hydrolyzed by addition of a small amount of alcoholic hydroxide solution.
By neutralization and reprecipitation, there is obtained a stereoregular poly(2,4-pentadiene-1-ol).

2,4-pentadiene-1-oxytrimethylsilane (60 parts) and 1~)45Z96 divinyl-methoxysilane (10 parts) are mixed with 30 parts of ben-zene, containing 10 mol/l of diethylaluminium chloride, 10 mol/l of cobalt acetylacetonate and 10 mol/l of water (all three concentrations calculated on the total volume of the mixture).
The polymerization is carried out for 10 hours at ambient temperature. The three-dimensional polymer formed is swollen first in ethanol and then in alcoholic hydroxide. Then it is washed ~- with an alcohol - water (1 : 1) mixture and which water and finally is placed into a physiological saline solution.
EXAMPLE S
- A macroporous gel is prepared by copolymerization of a mixture consisting of 10 parts of acetone, 17 parts of 2,4-pentadiene-l-ol, 2 parts of ethylene dimethacrylate and 1 part of 2,2'-azobis-2,4-dimethyl-4-methoxyvaleronitrile. The aforesaid mixture is charged into a thick-walled glass vessel, through ;
nitrogen was bubbed, it was thereafter sealed and polymerized for ....
25 hours of 45C.

An ethanolic solution containing 10% of 2,4-pentadiene-l-ol and 1 wt.% of methyl azobisisobutyrate is charged into a glass vessel and polymerized for 15 hours at 65 C in an inert atmosphere. An insoluble film is prepared from the obtained solution by addition of 1 wt.% of diisocyanate (e.g. 2,4-toluene-diisocyanate), casting onto a glass plate and heating to 120C
for 30 minutes. The prepared film may be used e.g. for separations of salt solutions by reverse osmosis or for surface treatment of roads and building materials (concrete etc).

A mixture of 2,4-pentadiene-1-ol and glycerol metha-crylate t4 : 1~ was dissolved in pyridine form a 5~ solution, 1 wt.~ of methyl azobislsobutyrate and 0.1% of CBr4 were added and the polymerization was carried out in a glass kettle in an 1~4SZ96 inert atmosphere for 10 hours at 60 C. The polymer formed is precipitated into an excess of diethylether, dried in vacuo, and ` dissolved in ethanol to form a 7% solution. This solution can be used for the preparation of highly elastic foils by evaporation of the solvent from the cast film and, if needed, the film can be additionally cross-linked to become insoluble. Thus, for example 0.8 wt.% of (NH4)2Cr2O7 based on the weight of the polymer) was added to 100 wt.% of the solution having the above composi- -~
tion as a 20% aqueous solution. The cross-linked film was obtained after 16 hours-at ambient temperature. This procedure can be used for coating catheters and other medical tools.

. ~ .
'' - :
''' , ' :' ' ~ ' .'' . . .
:, .
' . .

,~
.. : . . .

Claims (12)

The emdobiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A method for producing biologically acceptable polymers, comprising polymerizing monomers containing at least 60 mole % of dienols having from 5 to 10 carbon atoms in straight chain and at least one -OH group according to a radical mechanism or an ionic coordination mechanism, by using an azo initiator or in the presence of a catalyst consisting of a mixture of polyalkyl aluminium with Rh acetylacetonate, Co acetylacetonate or TiC13, respectively, with the proviso that when the polymerization is carried out according to an ionic coor-dination mechanism, the -OH groups of the dienols are previously blocked in a reversible manner by reaction with Cl-Si(CH3)3 and subsequently released by hydrolysis.
2. A method according to claim 1, comprising polymerizing monomers containing at least 60 mole % of dienols having from 5 to 10 carbon atoms in straight chain and at least one -OH group previously blocked in a reversible manner by reaction with Cl-Si(CH3)3, in the presence of a catalyst consisting of a mixture of a polyalkyl aluminium with Rh acetyl-acetonate or Co acetylacetonate, and subsequently hydrolyzing the obtained polymer to release the -OH group.
3. A method according to claim 1, comprising polymerizing monomers containing at least 60 mole % of dienols having from 5 to 10 carbon atoms in straight chain and at least one -OH group by using an azo initiator.
4. A method according to claim 1, 2 or 3, wherein the polymerization is carried out in a solvent.
5. A method according to claim 1, 2 or 3, wherein the polymerization is carried out in a solvent from the group consisting of alcohols having 1 to 5 carbon atoms, dimethylfor-mamide, dimethylsulfoxide, glycol monoethylether, pyridine and benzene.
6. A method according to claim 1, 2 or 3, wherein the polymerization is carried out in the presence of a chain transfer agent.
7. A method according to claim 1, 2 or 3, wherein the polymerization is carried out in the presence of a chain transfer agent selected from the group consisting of tetrabromomethane and mercaptans.
8. A method according to claim 1, 2 or 3, wherein the polymerization is carried out in the presence of a cross-linked agent.
9. A method according to claim 1, 2 or 3, wherein the polymerization is carried out in the presence of a cross-linking agent selected from the group consisting of glycol dimethacrylate, 1,6-heptadiene-4-ol, divinylcarbinol, methylenebisacrylamide, 1,1,1-triethylpropane triacrylate, bis-phenol A dimethacrylate, and 1,5-hexadiene-1-ol.
10. A method according to claim 1, 2 or 3, wherein after the polymerization is completed the polymer is additionally cross-linked by bifunctional compounds capable of reacting with -OH groups or -C=C- bonds present in the polymer.
11. A method according to claim 1, 2 or 3, wherein after the polymerization is completed, the polymer is additionally cross-linked by bifunctional compounds selected from the groups consisting of isocyanates, ammonium dichromate, dialdehydes and dicarboxylic acids.
12. A method according to claim 1, 2 or 3, wherein the polymerization is carried out with monomers consisting of a mixture of vinyl unsaturated compounds and dienols, the concentration of dienols in the monomer mixture being of at least 60 mole %.
CA174,171A 1972-06-16 1973-06-15 Method for producing new biologically tolerated polymers Expired CA1045296A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS422172A CS161327B1 (en) 1972-06-16 1972-06-16

Publications (1)

Publication Number Publication Date
CA1045296A true CA1045296A (en) 1978-12-26

Family

ID=5384460

Family Applications (1)

Application Number Title Priority Date Filing Date
CA174,171A Expired CA1045296A (en) 1972-06-16 1973-06-15 Method for producing new biologically tolerated polymers

Country Status (11)

Country Link
JP (1) JPS4952281A (en)
AU (1) AU477290B2 (en)
CA (1) CA1045296A (en)
CH (1) CH583756A5 (en)
CS (1) CS161327B1 (en)
DE (1) DE2325169A1 (en)
FR (1) FR2189431B1 (en)
GB (1) GB1428436A (en)
IT (1) IT987928B (en)
NL (1) NL7307697A (en)
SE (1) SE396953B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2125685A (en) * 1935-03-16 1938-08-02 Ig Farbenindustrie Ag Polymerization products and process of preparing them
US3041320A (en) * 1961-05-01 1962-06-26 Monsanto Chemicals Copolymers of 2-hydroxymethyl butadienes and 1, 3-dienes

Also Published As

Publication number Publication date
GB1428436A (en) 1976-03-17
CS161327B1 (en) 1975-06-10
FR2189431B1 (en) 1977-09-09
IT987928B (en) 1975-03-20
NL7307697A (en) 1973-12-18
CH583756A5 (en) 1977-01-14
AU5702473A (en) 1974-12-19
AU477290B2 (en) 1976-10-21
JPS4952281A (en) 1974-05-21
FR2189431A1 (en) 1974-01-25
DE2325169A1 (en) 1974-01-03
SE396953B (en) 1977-10-10

Similar Documents

Publication Publication Date Title
US4279795A (en) Hydrophilic-hydrophobic graft copolymers for self-reinforcing hydrogels
US4074039A (en) Hydrophilic N,N-diethyl acrylamide copolymers
US4267295A (en) Polymeric compositions and hydrogels formed therefrom
US3963685A (en) Alcohol soluble hydrophilic polymer via aqueous polymerization
US4379864A (en) Polymeric compositions and hydrogels formed therefrom
US3931123A (en) Hydrophilic nitrite copolymers
NO158811B (en) WATER-ABSORBING POLYMER MIXTURE BASED ON A WATER SOLUBLE POLYMER OF A VINYL LACTAM AND A WATER SOLUBLE COPOLYMER.
CN108192020B (en) Preparation method of intelligent zwitterionic polymer material
KR20000012970A (en) Ph sensing polymer containing sulfonamide group and preparing it
EP0263605B1 (en) Wound dressing
US3878175A (en) Highly absorbent spongy polymer materials
CN106866883B (en) A method of the double Biomimetic Polymers of synthesis are reacted with amino based on aldehyde radical
GB2064556A (en) Water absorptive polymer composition
Ghazinezhad et al. A review of frontal polymerization in the chemical industry
US3642953A (en) Selectively sulfonated block copolymers and process for their preparation
US4543371A (en) Polymeric compositions and hydrogels formed therefrom
CN103214625A (en) Thermo-sensitive grafted hydrogel with function of resisting protein adsorption and preparation method thereof
CA1045296A (en) Method for producing new biologically tolerated polymers
JPS6039688B2 (en) Blood neophilic medical materials
US4745158A (en) Highly water-absorptive optical material
JP2804273B2 (en) Highly hydrous ophthalmic lens material
US3876594A (en) Method for producing of articles from hydrophilic polymers appropriate for repeated or long-term contact with living tissue or mucous membrane
GB1566249A (en) Hydrogels
Wickramasinhage et al. Tough polymeric hydrogels using ion-pair comonomers
JPS599565B2 (en) Novel medical hydrogel